Insulin Dosing Recommendations for Dexamethasone-Induced Hyperglycemia
For this patient now receiving only dexamethasone 4 mg at 08:00 h, discontinue Lantus entirely and administer NPH twice daily: 15 units at 08:00 h (with dexamethasone) and 8 units at 18:00-20:00 h, with an ISF of 1:25 and ICR of 1:10.
Rationale and Dosing Algorithm
NPH Dosing Strategy
The current glucose pattern shows afternoon/evening hyperglycemia (271 mg/dL at noon, 184 mg/dL at 08:00 h) with overnight stability (163 mg/dL at 02:00 h), which is classic for dexamethasone-induced hyperglycemia. When dexamethasone is administered, NPH should be given twice daily rather than once daily 1. The guidelines explicitly state: "Administer NPH twice daily instead if dexamethasone is given" 1.
Morning NPH (08:00 h): 15 units
- Calculate based on 0.1-0.3 units/kg for dexamethasone-induced hyperglycemia 2, 1
- For this 67 kg patient: 0.22 units/kg = approximately 15 units
- This represents roughly 2/3 of total NPH dose, given with the morning dexamethasone 2
Evening NPH (18:00-20:00 h): 8 units
- Represents 1/3 of total NPH dose to cover the prolonged afternoon/evening hyperglycemia from morning dexamethasone
- Given in early evening (not bedtime) to match dexamethasone's peak effect 2
Discontinue Lantus
Lantus should be discontinued entirely. The evidence shows that when using NPH for glucocorticoid-induced hyperglycemia, you either use NPH as add-on to existing basal insulin OR replace basal insulin with NPH 1. Since this patient is transitioning from twice-daily dexamethasone to once-daily dosing, the insulin regimen needs restructuring. Continuing Lantus alongside twice-daily NPH creates excessive basal coverage and hypoglycemia risk, particularly overnight when the patient's glucose is already well-controlled (120-163 mg/dL).
Insulin Sensitivity Factor (ISF)
ISF: 1:25 (1 unit lowers glucose by 25 mg/dL)
The guidelines recommend ISF 1:25 with target 150 mg/dL for glucocorticoid-induced hyperglycemia 1. The current ISF of 1:25 is appropriate and should be maintained. This is more conservative than the typical 1:50 rule (1800/TDD) to account for steroid-induced insulin resistance.
Insulin-to-Carbohydrate Ratio (ICR)
ICR: 1:10 (1 unit per 10 grams carbohydrate)
Current ICR of 1:8 is too aggressive. With the glucose pattern showing:
- 84g CHO at breakfast → 271 mg/dL at noon (87 mg/dL rise)
- 80g CHO at lunch → 152 mg/dL at 16:00 h (119 mg/dL drop, likely from NPH peak)
The patient needs approximately 1 unit per 10 grams carbohydrate. This accounts for:
- Reduced dexamethasone dose (from 8 mg total to 4 mg daily)
- Decreased insulin resistance
- Better matching of prandial insulin to carbohydrate intake
Critical Monitoring Points
Days 1-3 after steroid reduction:
- Check fasting glucose, pre-lunch, pre-dinner, and bedtime glucose
- Insulin requirements can decline rapidly after dexamethasone is reduced 2
- Adjust NPH doses by 10% daily based on glucose patterns 1
Hypoglycemia risk:
- Greatest risk is overnight and late afternoon when NPH peaks
- The twice-daily NPH regimen with dexamethasone shows similar hypoglycemia rates to once-daily regimens (0.1% severe hypoglycemia) 3
- If fasting glucose drops below 100 mg/dL, reduce evening NPH by 2 units
If glucose control inadequate:
- Increase morning NPH first (covers lunch hyperglycemia)
- Then adjust evening NPH (covers dinner/bedtime)
- Consider increasing total NPH dose up to 0.3 units/kg (20 units total) distributed 2/3 AM, 1/3 PM 2, 1
Common Pitfalls to Avoid
- Do not continue Lantus with twice-daily NPH - this creates overlapping basal coverage and hypoglycemia risk
- Do not give NPH only once daily with dexamethasone - dexamethasone's prolonged effect requires twice-daily NPH coverage 1
- Do not use the same NPH dose as when receiving twice-daily dexamethasone - reducing steroid dose requires proportional insulin reduction
- Do not give evening NPH at bedtime - give at 18:00-20:00 h to match dexamethasone's afternoon/evening hyperglycemic effect